Better Precision Imaging and Navigation of the Heart
The CARTOMERGE™ Image Integration Module enables electrophysiologists to create three dimensional (3-D) electro-anatomical maps that are registered with computed tomography (CT) or magnetic resonance images (MRI). Merging the CT/MRI with the CARTO™ XP system 3-D map gives electrophysiologists a more precise view of the heart, allowing them to more effectively navigate catheters to targeted points within the heart. Commenting on the procedure Dr Hugh Calkins of John Hopkins University said,
ÔÇ£Combining the accuracy of Biosense WebsterÔÇÖs catheter navigation technology with the anatomical detail of CT or MRI is a major technological advance in diagnosing complex arrhythmias.ÔÇØ
The CARTOMERGE Software Module, used with the Biosense Webster CARTO XP Electroanatomical Navigation System, allows physicians to accurately locate and map arrhythmias. The CARTOMERGE Module offers electrophysiologists image registration in three steps importing the CT or MRI, processing the image on a radiology or CARTO XP System workstation and registering the images, in response to the new technology. Biosense Webster President, Roy Tanaka, commented:
ÔÇ£Now electrophysiologists will know that what theyÔÇÖre seeing on the screen is an exact representation of the patientÔÇÖs anatomy. TheyÔÇÖll be able to relate their catheter movements to a screen visual that helps to eliminate the guesswork.ÔÇØ
The CARTOMERGE Image Integration Module combines the accuracy of the CARTO XP Navigation System with the precision of pre-acquired 3-D CT or MRI. CARTOMERGE provides accurate anatomical registration for greater confidence in navigation. It requires minimal point acquisition for effective development of treatment strategy. It allows quick and easy processing of pre-acquired images into multiple cardiac structures, and provides new tools for procedure planning and targeting.
Additional benefits of the CARTOMERGE Image Integration Module include full digital images and communications in medicine (DICOM) 3 compatibility, minimal point acquisition for effective development of treatment strategy, new tools for procedure planning and targeting and improved speed of the system.
Biosense Webster pioneered electrophysiological (EP) diagnostic catheters more than 30 years ago and continues to lead the industry as an innovative provider of advanced diagnostic, therapeutic and mapping tools. Due to their status as market share leader in navigation systems, Biosense WebsterÔÇÖs technology includes more than 900 systems installed worldwide in leading hospitals and teaching institutions. With proprietary products such as the CARTO XP Navigation System and the LASSO™ Circular Mapping Catheter, the company is changing the way electrophysiologists diagnose and treat arrhythmias.
Biosense Webster, Inc., is a member of the Johnson & Johnson family of companies marketing healthcare products in more than 175 countries. Johnson & Johnson is the worldÔÇÖs most comprehensive and broadly based manufacturer of healthcare products. Ôûá